Prestige Consumer Healthcare Inc. (NYSE:PBH) last week reported its latest annual results, which makes it a good time...
We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted a US recession when the S&P 500 Index was trading at the 3150 level. We also told you to short the market and buy […]
Shareholders of Prestige Consumer Healthcare Inc. (NYSE:PBH) will be pleased this week, given that the stock price is...
Q4 2020 Prestige Consumer Healthcare Inc Earnings Call
Prestige Consumer Healthcare Inc. (PBH) today announced that the Company’s Board of Directors authorized the repurchase of up to $25.0 million of the Company’s issued and outstanding common stock. Separately, the Company plans to present at the Raymond James Institutional Investors Conference at 8:40 a.m. ET today, March 2nd.
PBH vs. UNICY: Which Stock Is the Better Value Option?
Prestige Brands (PBH) delivered earnings and revenue surprises of 8.00% and 0.42%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?
On the call with me today are Ron Lombardi, our Chairman, President and CEO; and Chris Sacco, our CFO. On today's call, we'll begin with some topical remarks, given the current crisis, review the results of the fourth quarter and fiscal year 2020, discuss our approach and initial thoughts on fiscal 2021 and then take questions from analysts. There's a slide presentation which accompanies today's call, can be accessed by visiting prestigeconsumerhealthcare.com, clicking on the Investors link and then on today's webcast and presentation.
Prestige Consumer Healthcare Inc. (PBH) is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front.
Revenue was $251.2 Million in Q4 and $963.0 Million in Full-Year Fiscal 2020Organic Revenue Grew 4.6% in Q4 and 1.3% in Fiscal 2020Generated Cash from Operations of $217.1.
Prestige Consumer's (PBH) third-quarter fiscal 2020 results reflect strength in the International segment and robust consumption trends at core brands. However, retailer inventory reductions persist.
Revenue $241.6 Million in Q3 Fiscal 2020; Organic Revenue up 0.5% versus Prior Year Q3GAAP Diluted EPS of $0.75 in Q3 Fiscal 2020; Adjusted EPS of $0.81, Up 11% Versus Prior.
In this article we are going to estimate the intrinsic value of Prestige Consumer Healthcare Inc. (NYSE:PBH) by taking...
As of late, it has definitely been a great time to be an investor in Prestige Consumer Healthcare.
TARRYTOWN, N.Y., April 27, 2020 -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2020 fourth quarter and year-end earnings release.
Prestige Brands (PBH) delivered earnings and revenue surprises of 10.81% and 4.48%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
Prestige Brands (PBH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Mega-merger, diworsification and digital disruption Continue reading...
Q3 2020 Prestige Consumer Healthcare Inc Earnings Call
NEW YORK, NY / ACCESSWIRE / February 6, 2020 / Prestige Consumer Healthcare, Inc. (NYSE:PBH) will be discussing their earnings results in their 2020 Third Quarter Earnings call to be held on February 6, ...